NYSE - Delayed Quote USD
ADC Therapeutics SA (ADCT)
1.9700
-0.1800
(-8.37%)
At close: May 21 at 4:00:02 PM EDT
2.0100
+0.04
+(2.03%)
Pre-Market: 7:27:05 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-136,074
-123,835
-118,686
-138,311
-233,378
Investing Cash Flow
-600
-867
-3,216
-687
-6,673
Financing Cash Flow
96,969
97,054
73,875
-897
267,394
End Cash Position
194,580
250,867
278,598
326,441
466,544
Interest Paid Supplemental Data
13,374
15,702
15,387
10,178
--
Capital Expenditure
-600
-867
-3,216
-687
-6,376
Issuance of Capital Stock
--
60,506
0
6,130
0
Issuance of Debt
--
--
0
115,597
49,591
Repayment of Debt
--
--
--
-1,011
-977
Repurchase of Capital Stock
--
--
--
-221
0
Free Cash Flow
-136,674
-124,702
-121,902
-138,998
-239,754
12/31/2021 - 5/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNDX Syndax Pharmaceuticals, Inc.
10.65
+0.76%
STRO Sutro Biopharma, Inc.
0.8383
-6.82%
REPL Replimune Group, Inc.
8.46
-7.94%
CTMX CytomX Therapeutics, Inc.
2.0400
-0.97%
TNGX Tango Therapeutics, Inc.
1.8900
-8.70%
MRSN Mersana Therapeutics, Inc.
0.3533
-9.41%
BCYC Bicycle Therapeutics plc
8.05
-5.41%
ANNX Annexon, Inc.
1.9700
-6.19%
TIL Instil Bio, Inc.
16.22
-1.34%
KPTI Karyopharm Therapeutics Inc.
4.7000
-8.83%